We investigated the association of fluid overload and oxygenation, and correlated with outcomes (duration of ventilation, ICU stay and mortality). We also assessed whether renal angina index (RAI) at admission, can predict acute kidney injury (AKI) on day 3, and mortality. Design and setting: Prospective study, pediatric intensive care in a tertiary hospital Duration: June 2013-June 2014 Patients: Need for invasive mechanical ventilation for >24 hr and presence of an indwelling arterial catheter. Patients with congenital heart disease or those who received renal replacement therapy were excluded. Methods: Oxygenation index, fluid overload percent (daily, cumulative), RAI at admission and pediatric logistic organ dysfunction (PELOD) score were obtained in all critically ill children. Admission data included for determination of RAI included the use of vasopressors; invasive mechanical ventilation; percent fluid overload and change in kidney function (estimated creatinine clearance). Univariate and multivariate approaches were used to assess the independent relation between fluid overload, oxygenation index and clinical outcomes. RAI cutoff >8 was used to analyze the predictive performance to predict AKI on day 3 of admission and mortality. Results: 102 patients were recruited. Fluid overload predicted oxygenation index, independent of age, gender and PELOD score (P <0.05). Peak fluid overload was associated with longer duration of ventilation, and intensive care unit and hospital length of stay (P <0.05), controlled for age and gender, PELOD. Day-3 AKI rates were higher in patients with RAI of 8 or more with the area under the curve of RAI higher for predicting Day-3 AKI. An RAI <8 had high negative predictive values (92-99%) for Day-3 AKI. RAI was as good as traditional markers of pediatric severity of illness (pediatric risk of mortality) for prediction of AKI on day 3. Conclusions: This study emphasizes that positive fluid balance adversely affects the intensive care unit course in critically ill children. Renal angina index prediction model may further help in a reliable prediction of AKI and help optimize treatment.
Background: Foxp3 + regulatory T cells (Tregs) participate in the repair of renal ischemia reperfusion injury (IRI). Others have shown that galactin-9 (Gal-9), a β-galactoside binding mammalian lectin, binds to negative regulatory molecule Tim-3 on CD4 + T cells and regulates immune responses by increasing Foxp3 + Treg in vitro and in vivo. Objectives: To study if activation of Tim-3/Gal-9 pathway promotes proliferation of Foxp3 + Treg in mice with renal IRI. Methods: The left renal pedicle was clamped in C57BL6 male mice for 45 min, followed by reperfusion. Animals were sacrificed at baseline, and day 1, 3, 10, 21 after renal IRI. Expression of renal Gal-9 was detected by real-time RT-PCR, immunohistochemistry staining and Western blot. Tim-3 in kidney mononuclear cells (KMNC) was determined using real-time RT-PCR and flow cytometry. The percentage of Foxp3 + Treg in KMNC and renal Foxp3 mRNA in kidney were measured with flow cytometry and real-time RT-PCR. To research the influence of Tim-3/Gal-9 pathway to the proliferation of Foxp3 + Treg and the protection effect of renal IRI, recombinant adeno associated virus (rAAV) carrying Gal-9 was injected to mice two days before kidney IRI surgery in order to overexpress Gal-9 and activate Tim-3/Gal-9 pathway. The proportion of Foxp3 + Tregs, Foxp3 mRNA and cytokines (TNF-α, IFN-γ, IL-10 and TGF-β) in kidney were evaluated on day 3, 10 and 21. Results: The expression of Gal-9 and Tim-3 in the injured kidney at day3, 10 and 21 increased significantly compared with injured kidney at day 1 and baseline (P<0. 05). The percentage of Foxp3 + Treg in CD4 + T cells and Foxp3 mRNAwas up-regulated with time. The mRNA expression of Gal-9 and Tim-3 was positively correlated with the percentage of Foxp3 + Tregs and Foxp3 mRNA at day 3, 10 and 21. Mice treated with RAAV carrying Gal-9 were significantly protected from renal IRI. Over expression of Gal-9 decreased the level of inflammatory cytokines (TNF-α and IFN-γ) and increased the levels of IL-10 and TGF-β in injured kidney. Furthermore, the proportion of Foxp3 + Treg cells and the level of Foxp3 mRNA in injured kidney were significantly higher than those in uninjured kidney and adenovirus group. Conclusion: Tim-3/Gal-9 pathway involves proliferation of Foxp3 + Treg in mice with renal IRI. Gal-9 is a potential therapeutic target in renal IRI. cholecalciferol supplements in past 3 months, or currently receiving sevelamer, statins, cinacalcet and corticosteroids were excluded. Results: Of 71 patients with CKD stage II-IV screened, 41 had vitamin D insufficiency. The rise in median (95% CI) FGF-23 levels after intervention from 157.3 (99.6-181.9) to169.4 (133.7-215.8 ) RU/ml was not statistically significant (P=0.3). Median phosphate levels did not rise after intervention (4.6 vs. 4.9 mg/dl) (P=0.8). However, on subgroup analysis, median FGF-23 increased significantly from 77.4 (55.8-128.5 ) RU/ml to 140.9 (77.4-177.4) RU/ml (P=0.01) and phosphate increased significantly from 4.7 (4.2-5.1) pg/ml to 5.0 (4.7-5.2) pg/ml in stage II CKD (P=0.01). Median calcium levels increased significantly from 9.1 (8.9-9.5) to 9.5 (9.2-9.8) mg/dl (P=0.02). The alkaline phosphatase and parathormone levels reduced from 742 (600-871) to 615 (553-723) IU (P <0.001) and 72.5 (43-93) to 50.8 (28-67) (P <0.001), respectively. Median 25-hydroxyvitamin D levels rose from 13 (11-18.5) to 50 (39-62) ng/ml (P <0.001). The change in median FMD after intervention from 7.7 (5.2-8.7) to 8.3 (5.8-9.0) % was not significant (P=0.6).
Conclusions: There is a high prevalence of vitamin D insufficiency in Indian children with CKD II to IV and is effectively corrected by high dose cholecalciferol. Cholecalciferol supplementation leads to rise in phosphate & FGF-23 level in early CKD, but not later stages. There is no change in brachial artery FMD with cholecalciferol supplementation. Estimated GFR is an independent predictor of FGF levels.
A composite risk score of novel biomarkers predicts arteriopathy in pediatric CKD and ESRD Background: Children with chronic kidney disease (CKD) have increased risk of death from cardiovascular disease. This study explored novel biomarkers for early detection of arteriopathy among high-risk children with CKD. Methods: 16 pre-dialysis CKD stages 3-4 (Group 1) and 25 CKD stage 5D patients (Group 2) were recruited. High resolution B-mode ultrasonography was performed on carotid, brachial and femoral arteries and arteriopathy parameters measured were augmentation index, pulse wave velocity/height, age-height standardized carotid and femoral intimamedia thickness, stiffness parameter and flow-mediated dilatation. An arteriopathy score was computed by adding the scores of individual arteriopathy parameters (abnormal=1, normal=0). ABPM was performed, and diastolic and systolic BP scores were calculated by adding individual scores for 24-h, wake, sleep blood pressure index and load and dipping. Biomarkers such as time averaged hemoglobin, uric acid, calcium, phosphate and parathormone were examined. Novel biomarkers such as serum GDF-15, ST2, hsTNT, homocysteine, ADMA, hsCRP, NT-proBNP and urine NGAL were examined. An ROC model using the odds ratios as the risk score from a multivariate logistic regression on univariate significant clinical and biochemical parameters was developed. Results: All patients, mean age 16.2±6.6 years and CKD duration 4.2±3.7 years, had at least one abnormal arteriopathy parameter (median arteriopathy score=4). Only pulse wave velocity/height [PWV (ht)] was significantly different between group 1 (3.3±0.7 m/s) and group 2 (4.1±0.9 m/s) (P=0.006). Parameters which were associated with abnormal PWV (ht) (defined as ≥3.74 m/s) were uric acid, diastolic BP score >5, GDF-15, hsTNT, ADMA and NTproBNP. The risk score model developed including these parameters had AUC of 0.806. Using a threshold score of 15, the sensitivity, specificity, PPV and NPV were 76.2%, 85.0%, 84.2% and 77.3% respectively. Conclusion: Arteriopathy abnormalities were detected in all patients with CKD, with significant worsening of vascular reactivity as measured by PWV in advanced CKD stage 5. The composite risk score model developed is a useful predictor of severe arteriopathy in CKD.
Growth in children with chronic kidney disease: report from Korean cohort study for outcome in patients with pediatric chronic kidney disease (KNOW- Objectives: Dysregulation of complement factor H (CFH) results in kidney disease. One mechanism is production of anti-factor H autoantibodies (aFH) as atypical hemolytic uremic syndrome defining the autoimmune form (AI-aHUS), leading to acute renal insufficiency. Anti-FH antibodies are also present in some chronic diseases comprising C3 glomerulopathies (GP), dense deposit disease & type I membranoproliferative GN leading to progressive renal insufficiency. This study compares the functional consequences of aFH developed in context of GP and AI-aHUS. Methods: Samples from 7 children (mean age 7.5 yr) presenting with GP associated with aFH were studied. Samples from17 children with AIaHUS (mean age 8.9 yr) were used as controls. Immune complexes quantification and epitope mapping of aFH were performed by ELISA; cell lysis assays were performed using non sensitized sheep erythrocytes and genetic analysis was performed by MLPA. Results: GP and AI-aHUS patients had comparable antibody titers, but GP patients had very low FH-anti-FH IgG circulating immune complexes (CIC) in comparison to aHUS patients. Epitope mapping revealed that aFH bound to only the N-terminal part in GP, whereas they bound to both N and C-terminal domains of FH in AI-aHUS. Cell lysis assays showed low levels of lysis with GP samples as compared to AI-aHUS samples. None of the GP patients had homozygous CFHR1/R3 deletion, which is the predisposing factor for AI-aHUS; 6/7 patients were C3Nef positive. Conclusions: Anti-factor H autoantibodies of GP bound to epitopes different from AI-aHUS and impair the alternative pathway in a distinct mechanism. They are not developed in the same genetic condition. This data provides an insight of differences between aHUS and GP and also an example of autoantibodies directed against the same protein associated with two pathologically distinct diseases. Background: Dense deposit disease (DDD) and C3 glomerulonephritis (C3GN), classified together as C3 glomerulopathy, are rare diseases characterized by glomerular deposition of C3 without significant immunoglobulin deposits. Information on management and outcomes of C3 glomerulopathies is limited to case series. Methods: Records of patients, 1-18 yr-old, with biopsy between 2004 and 2014 were reviewed to identify patients with C3 glomerulopathy. Diagnosis was based on light microscopy suggesting proliferative GN, with glomerular C3 staining in absence of immunoglobulin on immunofluorescence, and electron dense deposits that are intramembranous (DDD) or in subendothelial and mesangial location (C3GN). Results: 22 children (59% boys) were diagnosed with DDD (n=19) or C3GN (n=3) at mean±SD age 9.6±2.2 yr. Findings included anasarca (n=22), hematuria (n=6), stage II hypertension (n=13) and nephrotic range proteinuria (21); renal function was impaired at onset in 41%. Indications for biopsy were steroid resistant nephrotic syndrome (54%), atypical GN (18%) and rapidly progressive GN (23%). Low levels of complement C3 were present in 91% patients. Investigations excluded lupus, HIVand hepatitis B and C in all patients. There were no differences in clinical features between patients with DDD and C3GN. Light microscopy confirmed basement membrane thickening and splitting in 70% cases. Patients received therapy with prednisolone and enalapril (100%) along with mycophenolate mofetil (72%), cyclophosphamide (27%), tacrolimus (13%) or rituximab (18%); therapeutic plasmapheresis was performed in 3 patients for rapidly progressive glomerulonephritis & in one for disease recurrence in the allograft. Five patients progressed to chronic kidney disease stage 5 over 3 months to 10.7 yr. Conclusions: Membranoproliferative pattern of injury is not universal in C3 glomerulopathy. Presentation and disease course are heterogeneous and response to therapy is variable. A significant proportion of patients progresses to advanced kidney disease.
Nationwide data on anti-complement factor H associated hemolytic uremic syndrome A. Bagga, A. Sinha, A. Gupta, S. Saini on behalf of HUS database Division of Pediatric Nephrology, All India Institute of Medical Sciences, New Delhi, India Objectives: Antibodies to complement factor H (CFH) are an important cause of atypical hemolytic uremic syndrome (HUS) in children, where specific therapy enables satisfactory outcomes.
Results: We report findings from a multicenter cohort of 209 Indian children with anti-CFH antibodies, constituting 55.4% patients with HUS. Antibody titers, chiefly IgG3, were high (mean ±SEM 7436±1374 AU/ml) & correlated inversely with levels of C3, but not CFH. Homozygous CFHR1 deletion was found in 88% patients & 9% healthy subjects. Therapies included dialysis (86%) and plasma exchanges (PEX, 76%). Median decline of antibodies was 74%, 88% & 84% after 3, 5 & 7 PEX respectively (P=0.08). Induction consisted of prednisone & IV cyclophosphamide or rituximab; serial antibody titers over 12-months were similar in those receiving either therapy (GEE; P=0.63). Adverse outcome (stage 4-5 CKD, death) was seen in 26% at 3-mo and 30% at follow up; 6-mo from the onset, 11% had relapses. Risk factors for adverse outcome were antibody titer >8000 AU/ml, low C3 & delayed PEX; titer >1300 AU/ml at 6-mo predicted relapses (sensitivity 80%, specificity 76%). Combined PEX & induction therapy resulted in better renal survival; one adverse outcome prevented for every 2.6 patients treated. Maintenance immunosuppression reduced the risk of relapses. Conclusions: Anti-CFH antibody associated HUS associated with homozygous deletion in CFHR1 affects school children and is characterized by severe features. Prompt PEX & immunosuppressive agents are useful for improving outcomes. Patients with persistent high antibody titers are at risk of relapses.
When to start and how to stop eculizumab in children with atypical hemolytic uremic syndrome? 4 Department of Blood Transfusion Medicine, Nara Medical University, Japan Introduction: Diagnosis of atypical hemolytic uremic syndrome (aHUS), particularly in infants, is difficult and may be detrimental to outcome. Eculizumab (ECZ) can be a first-line therapy for aHUS, but the rationale for long-term use of ECZ needs to be carefully discussed. Cases: We experienced 4 patients with suspected aHUS in whom ECZ was administered from the acute phase. ECZ was discontinued in only 1 patient, without relapse of HUS. In this case, after confirmation of negative stool culture, ECZ was started. However, after more detailed investigation of stool culture, enterohemorrhagic Escherichia coli O76 was detected and lead to diagnosis of typical HUS. In others, lacking definite etiological confirmation, ECZ has been continued without significant side effects. Discussion: We recommend that ECZ treatment be started as soon as aHUS is suspected, because early treatment results in better prognosis, and complication of plasma exchange, particularly for infants, can be avoided. Concerns with long-term use of ECZ include: (i) increased risk for infection by encapsulated organisms; (ii) unknown long-term side effects; and (iii) frequent and regular administration has negative impact on patients' QOL. These concerns should be balanced against the risk of relapse of thrombotic microangiopathy, not only in the kidney, but also in other critical organs. Improvement of detection rate of relevant gene mutations is also warranted. Conclusion: ECZ is effective in acute phase of aHUS, but rationale for its long-term use has yet to be established. Objective: Congenital anomalies of the kidney and urinary tract (CAKUT) account for 40-50% of children with chronic kidney disease. The aim of this study was to determine patients with CAKUT that could be explained by mutations in 17 known dominant CAKUT-causing genes. Method: By next generation sequence technology, we analyzed the coding exons and UTR of 17 known dominant CAKUT-causing genes in 7 patients (vesicoureteric reflux in 3; ureteropelvic junction obstruction, ureterovesical junction obstruction, renal aplasia and agenesis 1 each). The genes were: BMP4, BMP7, CDC5L, CHD1L, EYA1, GATA3, HNF1B, PAX2, RET, ROBO2, SALL1, SIX1, SIX2, SIX5, SOX17, UMOD, and UPK3A. Result: We identified 19 novel heterozygous mutations in 10 of the 17 known genes: PAX2 (2), GATA3 (1), RET (2), ROBO2 (1), UMOD (1), SALL1 (2), SOX17 (3), SIX5 (4), BMP4 (2), HNF1B (1). 14 were nonsynonymous mutations in the coding sequence, 2 were located in splice sites and 3 were UTR variations. Damaging mutations predicted by Sift and Polyphen 2 were: PAX2: c.1094A>C, P.365N>T; GATA3: c.466A>C, p.156T>P; ROBO2: c.775-c.779 frameshift deletion. The PAX2 mutation was seen in one patient each with VUR and UVJO; ROBO2 deletion was seen with UVJO; GATA3 mutation was seen in the patient with unilateral VUR. Conclusion: To date, 23 monogenic CAKUT-causing genes have been identified that result in isolated CAKUT or syndromic CAKUT with mild extra-renal manifestations, most of which are dominant inheritance. Our research revealed that GATA3, PAX2, ROBO2 are common disease causing genes in CAKUT patients, which is coincident with previous reports. More samples are needed to identify the relation between genotype and phenotype by next generation sequencing. Objectives: To determine the frequency and clinico-genetic correlation of NPHP2 and NPHP3 mutations in cases of infantile NPHP Method: Of 15 patients included, DNA was available in 14 patients. NPHP1 homozygous deletion was excluded by PCR amplification of satellite markers initially. All patients were screened for mutations and polymorphisms with Sanger sequencing in NPHP2 and NPHP3. Results: We identified NPHP3 mutations in 8 patients: compound mutations in 7 (P1~P7) and a heterozygous mutation in P8. There were 11 novel mutations (p.Ala434 del, p.Glu602Glyfs621X, p.Gln153Pro, p.Lys678X, p.Cys816X, p.Asn711Ser, p.Arg756Gln, ISV9-40T→G, p.Asp216His, IVS13-11T→G, ISV14+5 G→A, respectively) and 2 known mutations (p.Leu790Pro, p.Arg973Pro). P9 was from the same family and considered with the same mutation as P8. All patients (P1~P9) had growth retardation; anemia was seen in 7, liver lesion (P3) and respiratory infection (P5) in one patient each. All presented with ESRD before 5-yr age, except for P8. Renal pathology was diverse with predominantly chronic tubulointerstitial nephritis and tubular cysts, dilated Bowman capsule, irregular tubular basement membrane, and glomerulosclerosis or mesangial proliferation. Eight patients had hepatic involvement, and one each had congenital heart disease and hypothyroidism with thyroid cyst. Only1 patient had NPHP2 mutation, which progressed to ESRD at 1 month and had inguinal hernia. Conclusion: NPHP2 and NPHP3 mutations in infantile NPHP were high (64.3%); patients with NPHP3 mutations also had liver lesions. Objective: To explore the pathogenesis of tubular interstitial fibrosis in nephronophthisis type I Methods: The expression of NPHP1 in MDCK cells were knockdown by siRNA. Cell morphology and cell migration were observed under microscope. The expressions of E-cadherin, β-catenin, ZO-1, ZONAB and α-SMA both in mRNA and in protein were analyzed by real time PCR, western blot and immunofluorescence, respectively. The mRNA levels of MMP-2, MMP-9 and FSP-1 were detected by real time PCR. The activity of MMP-2 and MMP-9 were detected by gelatin zymography. Result: MDCK cells become elongated and the migration capacity enhanced after NPHP1 knockdown. The expressions of E-cadherin, β-catenin and ZO-1 decreased whereas ZONAB increased both in mRNA and in protein in NPHP1 knockdown MDCK cells. mRNA expression of FSP-1 and the protein level of α-SMA were both increased. Both mRNA expressions and activities of MMP-9 and MMP-2 were increased. Objectives: Maternal protein restriction results in intrauterine growth restriction (IUGR) with reduced nephron number. We studied the expression of perlecan in kidney development of IUGR rat and association with cell apoptosis and proliferation level to investigate its role in prenatal kidney programming. Methods: IUGR rat model was established with maternal lowprotein (6%) isocaloric diets through gestation. mRNA transcription of perlecan during kidney development was detected by real-time PCR. Perlecan immunohistochemistry was performed to show protein expression. Ki-67 and TUNEL were applied to mark proliferation and apoptotic cells; changes of cell apoptosis and proliferation level were detected. Results: 1. At four weeks postnatally, IUGR offspring had fewer glomeruli per kidney than those in controls (2670±213 vs. 3666±2889, P<0.05). IUGR newborn weights were significantly lower. 2. In embryonic period overall, perlecan mRNA transcription level gradually increased and then to a lower level for four weeks after birth. Introduction: The pathogenesis of chronic CsA-induced nephropathy is multifactorial. The main factors include (i) activation of the intrarenal renin-angiotensin system (RAS), (ii) renal ischemia via arteriolar constriction, (iii) increases in transforming growth factor (TGF-β1) and inflammatory cytokines such as osteopontin (OPN). Objective: Mizoribine (MZR) suppresses infiltration of macrophages, which play a role in development of interstitial fibrosis. Since the RAS plays an important role in pathogenesis of chronic CsA induced nephropathy, blocking this system with either losartan (LSRT), or angiotensin converting enzyme inhibitors (ACEI) suppresses expression of proinflammatory mediators and profibrogenic cytokines. The study tested the hypothesis that the administration of MZR & LSAR prevents CsA induced chronic nephropathy in rats. Methods: Six-weeks old male Spraque Dawley rats maintained on low salt diet were given vehicle, CsA (15 mg/kg), CsA and LSRT (30 mg/kg/ day), CsA and MZR (5 mg/kg), or a combination of CsA, LSRT and MZR for 4 and 7 weeks. Blood chemistry and histopathology (tubular vacuolization and drop out, arteriolopathy, tubulointerstitial fibrosis, and inflammatory cell infiltration) was compared among treated groups. Inflammatory and fibrotic factors, OPN and TGF-β1 were studied by immunohistochemistry and quantification with real-time PCR. Results: MZR attenuated the tubular cell vacuolization and drop out at 4 weeks (P<0.05). MZR and MZR+LSRT reduced tubulointerstitial fibrosis at 7 weeks (P<0.01, P<0.05). Arteriolopathy was decreased in MZR+ LSRT at 7 weeks (P<0.05). OPN and TGF-β1 mRNA expression was decreased in MZR (P<0.01) and MZR+LSRT (P<0.05) at 4 weeks. OPN mRNA expression was decreased at 7 weeks in MZR+LSRT (P<0.05). TGF-β1 mRNA expression was decreased at 7 weeks in MZR (P<0.01) and MZR+LSRT (P<0.01). ED-1(+) cell decreased in MZR (P<0.05) and MZR+LSRT (P<0.05). Glomerular decreased in CsA group and recovered in MZR (P<0.01) and MZR+LSRT (P<0.05) at 7 weeks. Conclusions: This study shows that MZR has protective effects on inflammatory process in chronic CsA nephropathy and led to improvement of tubular damage, tubulointerstitial fibrosis and arteriolopathy by down regulation of OPN and TGF-β1. Combined treatment with MZR and LSRT provided synergistic effects in attenuating inflammatory and fibrotic processes in chronic CsA induced nephropathy. MZR & LSRT can potentially be used for protecting against CsA nephrotoxicity and glomerular size contraction as an adjuvant for long term CsA treatment. Objectives: Adriamycin (ADR) induced nephropathy is widely used animal model of progressive renal disease resulting in glomerulosclerosis, podocyte injury and fibrosis. The present study investigated the protective effects of human bone marrow derived mesenchymal stem cells (hBMSC) on ADR induced nephropathy rat model. Methods: Male Sprague-Dawley rats were divided into normal controls (Normal), ADR+Vehicle (CON) and ADR+hMSC (MSC) groups. Nephropathy was induced by single injection of ADR (4 mg/kg IV). Four days later, 0.5 ml of saline with or without 2×10 7 hBMSC was injected via tail vein for CON or MSC group. The rats were sacrificed 1 week and 6 weeks after ADR injection. hBMSC were characterized by cell surface CD marks expression as well as differentiation induction into osteoblasts and adipocytes. To evaluate homing of hBMSC, the cells were labeled with CFSE (5(6)-carboxyfluorescein N-hydroxysuccinimidyl ester) and examined several tissues 3 h after injection. Kidney and body weight, as well as serum level of protein, albumin, cholesterol, triglycerides and creatinine were measured at 1-and 6-weeks. Western blot for inflammatory cytokines, nephrin, type I collagen was carried out. Light and electron microscopic observation were done for structural analysis. Results and Conclusions: hBMSC were observed in lung, liver and spleen but hardly detected in kidney. There was no significant difference in body and kidney weight as well as serum levels of protein, albumin, cholesterol, triglycerides and creatinine between CON and MSC groups. Pro-inflammatory cytokines (COX2, TNF-α, INF-γ and IL-12) expression was decreased in MSC compared to CON but nephrin expression was increased. hBMSC have little effect for improving nephropathy by direct regeneration but preserve kidneys by indirect anti-inflammatory effect.
Dialysis
The development of pediatric peritoneal dialysis in China: Brief data report from IPPN China Objective: To investigate the development of pediatric peritoneal dialysis in China Methods: Analyze the data from IPPN China (www.pedpd.org.cn) Results: IPPN China is the Chinese version of International Pediatric Peritoneal Dialysis Network (IPPN). It is managed by Children's Hospital of Fudan University, to increase the communication among Chinese pediatric renal centers and improve the development of pediatric peritoneal dialysis in China. It was online on Jul. 2012. The members of IPPN China increased from 13 to 23 for now, which distributed in 19 cities from 16 provinces in China. The registered data of the year 2014 show the number of patients on the current chronic PD (CPD) is 113, distributed in 18 centers from 15 cities. These 18 centers can offer CAPD, among which 11 can offer APD. Among all the centers, only 3 have the current CPD patients more than 10, which cover 51.3% of all the CPD patients registered. Eight centers have improved significantly from 2012 to 2014, whose number of CPD patients increased 1.24~8 times. Children's Hospital of Fudan University is the biggest CPD center in China for now, with 36 cases of current CPD and over 80 in total. The percentage of patients with weekly Kt/V<1.8 has decreased from 7.7% to 5.7% between 2011 and 2014. The average level of Hb increased from 10.8±2.1 g/L to 11.5±2.5 g/L. The percentage of patients with severe LVH decreased from 38.5% to 27%. The peritonitis rate decreased from 26.5 per patient month to 40.1 per patient month. Conclusion: According to our data which represent some of the pediatric renal centers in China, many cities in China can offer CPD for pediatric patients. Although these centers are with different scale and level, most of them make progression in recent years. We believe that IPPN China, as a good communication platform, can help improving the development of pediatric CPD in China. India is a developing country in the lower middle income stratum (World Bank 2013, GNI per capita). The outcome in children with end stage renal disease (ESRD) depends on availability of health services. More than 70-80 percent children with ESRD do not receive any form of renal replacement therapy, chiefly due to financial constraints, lack of health care facilities and scarcity of trained physicians and technical staff that can cater to the specific needs of children and adolescents. Objectives: With the intent of providing free, state of art care to children with ESRD, who were awaiting kidney transplantation, an exclusive pediatric dialysis centre "Southend Sparsh" began services from June 2013. We report the activities undertaken at the unit and the achievements. Methods: Manpower for the 3-bed pediatric hemodialysis unit, inaugurated in June 2013, includes 1 pediatric nephrologist, 1 dialysis technician, 3 staff nurses and 1 nursing aid. The personnel were recruited and trained in pediatric dialysis at the All India Institute of Medical Sciences. Other challenges included generating funds and finding a center where the Unit could be located, in order to provide medical facilities in case of emergency. Funds were generated by Rotary Southend Charitable Trust, New Delhi and rent free space with optimum back up services was provided by Batra Hospital and Medical Research Centre, New Delhi. The cost of setting up a 3-bed dialysis unit was about INR 3.2 million, while the annual running cost is almost same at INR 3 million, which includes staff salaries and consumables. Annual cost does not include maintenance of hemodialysis machines and water treatment. The approximate cost of a single dialysis session at this center is INR 3250, which does not include other medications apart from those used during dialysis. Results: During one year , 28 patients (17 boys) have received a total of 1029 hemodialysis sessions. The chief cause of chronic kidney disease was steroid resistant nephrotic syndrome secondary to FSGS; the next diagnosis was atypical hemolytic uremic syndrome. Of 28 patients 2 needed support for acute kidney injury and eventually become dialysis independent. During 1029 dialysis sessions 197 adverse events were noted, including hypotension (32.9%), pain abdomen, dizziness, intradialytic hypertension, vomiting, catheter malfunction, muscle cramps, hypersensitivity reaction and headache. Four received kidney transplant, one was shifted to continuous ambulatory peritoneal dialysis, 2 patients with AKI improved and become dialysis independent; 5 were lost to follow up, 1 child died at home and 15 are undergoing hemodialysis. Conclusion: Considering the large number of children with ESRD, there is need for more dedicated pediatric dialysis centers, which provide comprehensive care to children.
Rotary Southend Sparsh Initiative: pediatric hemodialysis services in New Delhi
Vitamin C overload leads to secondary hyperoxalosis in young pediatric dialysis patients Objective: Vitamin C supplementation is recommended in dialysis patients to prevent anemia, gingival disease and scurvy. Case reports suggest that very large doses of vitamin C intake led to secondary hyperoxalosis in some adult dialysis patients. We sought to study the impact of current enteral formulas on vitamin C and oxalate levels in dialyzed children. Methods: We identified oxalate crystal deposits in bone of two 5-yearold hemodialysis patients who underwent routine bone biopsy prior to parathyroidectomy. Gene analysis for AGXT ruled out primary hyperoxaluria, and both had a history of high vitamin C intake from enteral feeding. Therefore, we assessed the daily recommended intake (DRI) of vitamin C from enteral feedings in 13 pediatric patients aged 8 months to 8 years fed primarily formula through a gastrostomy tube, treated with either hemodialysis (n=3) or peritoneal dialysis (n=10) in order to assess the impact on oxalate burden. Total vitamin C intake, serum oxalate levels and ascorbic acid levels were assessed in these patients. Results: All patients were receiving 1.2-8.3 times the DRI for vitamin C from enteral feedings. Ascorbic acid levels ranged from 1.5 to 10.0 mg/ dL (ref range: 0.2-1.9 mg/dL); values were elevated in 85% patients. Oxalate levels were elevated (>30 μmol/L) in 69% patients and ascorbic acid levels did not correlate with oxalate levels (r=0.44, P=0.13). Ascorbic acid and oxalate levels did not correlate with the amount of vitamin C received corrected by the DRI (r=0.42, P=0.15 and r=0.09, P=0.77 respectively). Conclusion: Oxalate deposition in bone demonstrates that oxalate is present in toxic levels in some dialyzed children; excess vitamin C ingestion contributes to secondary oxalosis in predominantly formulafed infants and children. Plasma ascorbic acid levels vary, correlate poorly with oxalate levels, and may not reflect total body stores, suggesting that a portion of ascorbic acid is unavailable for clearance during dialysis.
Retrospective study of arteriovenous fistula used in pediatric patients of ESRD L. Ying, S. Ning, W. Hui, S. Ying Department of Nephrology, Beijing Children Hospital, Beijing, PR China
Objective: To study the clinical features of arteriovenous-fistula (AVF) in pediatric patients who need maintenance hemodialysis. Methods: Comprehensive analyses were performed on data of patients who had AVF surgery in our hospital during June 2007 to April 2014, including clinical features and laboratory examination. Sex, choice of surgery side and vein, anesthesia, model of vascular suture were assessed with chi-square statistics respectively, age of surgery, inner diameter, hemoglobin, platelets, hematocrit, serum creatinine, prothrombin time, fibrinogen, activated prothrombin time were assessed with t-test respectively. Result: 41 male, average age of surgery was 10y11m (2y4m to 16y1m). Underlying diagnosis was chronic glomerulonephritis (29%), kidney dysplasia (27.4%), nephrotic syndrome (11.3%), reflux nephropathy (11.3%), obstructive nephropathy (4.8%) and others (24.2%). Average interval from diagnosis to surgery was 30.8 days. General anesthesia (n=42), brachial plexus block (n=7) were used. All AVF were made on forearm; 58 on left, 4 on right. 55 were radio-cephalic end-to-lateral anastomosis, 7 were radio-non cephalic anastomosis. Inner diameter of AVF was 2 mm in 22 (35.5%), 2.5 mm in 3 (4.8%), 3 mm in 31 (50%), 4 mm in 3(4.8%). We regarded "tremor and vascular bruit at the operative site 1 week after surgery" as success standard, success rate was 80.7% (50/62); failure rate was 19.4% (12/62). Acute complication were thrombosis in 6 (9.7%), errhysis in 5(8.0%), pain and swelling in 4 (6.5%), hemorrhage and anesthesia in fingers in 1 each (1.6%). Type of anesthesia, inner diameter of AVF and Hb affected success rate (P <0.05). Conclusion: The interval from diagnosis to surgery was shorter than suggested by 2006 NKF-KDOQI guidelines. We preferred to choose radiocephalic end-to-lateral anastomosis on left wrist. The most common acute complication was thrombosis and errhysis. Anesthesia, inner diameter of AVF and Hb may affect success rates.
Training evaluation results of caregivers in children's peritoneal dialysis and teachings on nursing intervention Q. Zhou, Ru-Ping Gao, Pei-Lian Yao, H. Zhang, J. Zhou, Er-Zhuang Qian, H. Xu Department of Nephrology and Rheumatology, Children's Hospital of Fudan University, Shanghai, China
Objective: To prevent peritonitis and other complications for children undergoing peritoneal dialysis (PD), the aim of this study is to analyze training evaluation results of home PD caregivers, and to explore the appropriate frequency of re-training. Methods: From Jan 2012 to Dec 2013, 32 children received surgical placement of PD catheters and obtained training certificates with their caregivers. Based on time intervals of training, the patients were divided into two groups: experimental group (every 3 months) and routine group (every 6 months). Hand-washing, exit-site care, continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) operating procedure were brought into evaluation standards. PD specialized nurses took charge of children in peri-operative period. Evaluation results and peritonitis incidences in the first 6 months after catheterizing were analyzed. Results: There is no statistic difference in the gender, age, education level of caregivers and surgical method between these two groups (P>0.05). Qualified rates of hand-washing and exit-site care were significantly higher in experimental group (87.5% and 81.25% respectively) than in routine group (both 37.5%, P<0.05). Compared with 31.25% of cases in routine group, peritonitis occurred zero in experimental group (P<0.05). Conclusion: Re-training and evaluating on home PD caregivers every 3 months, shows a positive effect on reducing peritonitis. However, further clinical randomized controlled trials are needed to explore an effective and reasonable training program for home PD caregivers, in accord with health economics.
Application of portable water-treatment system in chronic hemodialysis in children with end stage renal disease in China Objective: To explore the value and safety of single-bed mobile dialysis water treatment system in chronic hemodialysis (HD) in ESRD. Methods: Dialysis water produced by the portable water-treatment system, composed of water pretreatment device, water softening machine and reverse osmosis water treatment machine, was used for chronic HD. The water quality index as well as the dialysis adequacy, complications and outcome of 20 children with ESRD, on chronic HD in our center from Aug 2010 to Mar 2014, was analyzed. Before April 2013, the components of water pretreatment device were a PP polypropylene filter in series with two charcoal canisters. After May 2013, the components of water pretreatment device were the first PP polypropylene filter, quartz sand filter, activated carbon filter and the second PP polypropylene filter. Results: The water quality index, including endotoxin level, bacteria culture and heavy metals' level, were consistent with the criteria of standard operation procedures of blood purification (SOP) issued by the Chinese Ministry of Health. From May 2013, dialysis water endotoxin level was further decreased after the water pretreatment device was improved, with the quantitative values less than 0.5 EU/ml, of which, 85.2% was less than 0.25 EU/ml. During HD, there was no heat reaction, hemolysis, hard water syndrome and other water-related complications. The dialysis Kt/v was 1.2 ± 0.23 and urea clearance was 66.68 ± 7.32%. The achieved rate of hemoglobin, serum calcium, serum phosphorus and PTH after 6 months of HD were 66.7%, 53.3%, 13.3% and 20% respectively, 60%, 50%, 50% and 20% respectively after 12 months and 87.5%, 62.5%, 37.5% and 87.5% after 18 months. At the end of follow-up, patient survival rate was 95%; 11 cases returned to normal schooling during HD. Conclusion: The quality of dialysis water produced by portable watertreatment system conformed to the standard of dialysis water, which was superior to the criteria of SOP recommendation. The portable watertreatment system was suitable for children with chronic HD in China.
Glomerulonephritis and glomerular diseases
The validation study of Oxford Classification of IgA nephropathy in Chinese children Background: The Oxford classification of IgA nephropathy presented that four histopathological features had independent predictive value of clinical prognosis. Considering the limitations of study cohort, validation study in Chinese children is necessary. Methods: 223 children with IgA nephropathy from 4 centers in China were included. The inclusion criteria referred to the Oxford study. Results: Depending on the Oxford Classification, with scoring of pathological features, the extended pathology dataset included 18 pathological lesions. After analyzing the reproducibility and independency of these variables, 4 features were selected. Three lesions, mesangial proliferation, endocapillary proliferation and interstitial fibrosis/tubular atrophy were similar to original Oxford study (instead of segmental sclerosis/adhesion) and crescents were picked out. There were 165 (74%) with mesangial proliferation (M1), 153 (69%) with endocapillary proliferation (E1), 87 (39%) with crescent, 3 (1%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred) and 4 (2%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). In our single center study (156 patients) the median follow-up duration was 17 months; 80 patients had follow up >6 months. We completed the correlations study between pathological lesions and clinical prognostic indicators like proteinuria. Conclusions: Mesangial proliferation, endocapillary proliferation and crescents were common in Chinese children with IgA nephropathy then adults. The reproducibility of scoring of histological lesions was important in the classification.
DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy Q. Sun, J. Zhang, N. Zhou, X. Liu, Y. Shen Department of Nephrology, Beijing Children Hospital, Beijing, PR China Objectives: IgA nephropathy (IgAN) is one of the most common glomerular diseases leading to end-stage renal failure. Elevation of aberrantly glycosylated IgA1 is a key feature. The expression of the specific molecular chaperone of core1ß1, 3galactosyltransferase (Cosmc) is known to be reduced in IgAN. We aimed to investigate whether the methylation of CpG islands of Cosmc gene promoter reign could act as a possible mechanism responsible for down-regulation of Cosmc and related higher secretion of aberrantly glycosylated IgA1 in lymphocytes from children with IgA nephropathy. Methods: Three groups were included: IgAN children (n=26), other renal diseases (n=11) and healthy children (n=13). B-lymphocytes were isolated and cultured, treated or not with IL-4 or 5-Aza-2'-deoxycytidine (AZA). Results: The levels of DNA methylation of Cosmc promoter region were not different between the lymphocytes of the three children populations (P=0.113), but there were significant differences between IgAN lymphocytes and lymphocytes of the other two children populations after IL-4 (P<0.0001) or AZA (P<0.0001). Cosmc mRNA expression was low in IgAN lymphocytes compared to the other two groups (P<0.0001). The level of aberrantly glycosylated IgA1 was markedly higher in IgAN group compared to the other groups (P<0.0001). After treatment with IL-4, the levels of Cosmc DNA methylation and aberrantly glycosylated IgA1 in IgAN lymphocytes were remarkably higher than the other two groups (P<0.0001) with more markedly decreased Cosmc mRNA content (P<0.0001). After treatment with AZA, the levels in IgAN lymphocytes were decreased, but was still remarkably higher than the other two groups (P<0.0001), while Cosmc mRNA content in IgAN lymphocytes were more markedly increased than the other two groups (P<0.0001). The alteration of DNA methylation by IL-4 or AZA specifically correlates in IgAN lymphocytes with alterations in Cosmc mRNA expression and with the level of aberrantly glycosylated IgA1 (r= -0.95, r=0.71). Conclusion: Our results suggested that hypermethylation of Cosmc promoter reign could be a key mechanism for the reduction of Cosmc mRNA expression in IgAN lymphocytes with associated increase in aberrantly glycosylated IgA1.
Long-term outcomes with multi-targeted immunosuppressive protocol in severe pediatric lupus nephritis YW Lau, ET Aragon, LP Resontoc, YH Chan, KH Ng, Yeo WS, HK Yap Shaw-NKF-NUH Children's Kidney Center, National University Health System, Singapore
Background: The gold standard of treatment of proliferative lupus nephritis (LN) using corticosteroid and intravenous cyclophosphamide (CYC) resulted in improved patient and renal survival rate. Alternative treatment is the multi-targeted induction protocol using intravenous methylprednisolone, mycophenolate and cyclosporine to induce remission in our patients with severe proliferative lupus nephritis. This study examined the long-term renal outcomes using the multi-targeted induction and maintenance protocol.
Method: 16 children with severe proliferative LN (WHO class III and IV) treated with multi-targeted therapy were studied. Median follow-up was 9.2 yr (range 3.8-12.8). Primary treatment outcome was complete renal remission. Secondary outcomes were patient and renal survival and relapse-and event-free survival. Mixed-model analysis was performed to compare pre-induction and last follow-up parameters, adjusting for age at induction, gender, duration of disease prior to induction, prior treatment with CYC and/or azathioprine (AZA), and duration of follow-up. KaplanMeier was used to analyze relapse-and event-free survival. Results: All patients achieved complete renal remission within a median time of 8.7 months (range 4-24). Clinical and laboratory parameters at induction and last follow-up, SLEDAI score (25.4±8.7 vs. 0.4±0.8), serum C3 (47±15 vs. 107±27 mg/dL,), C4 (12±14 vs. 23±14 mg/dL) and urine protein (6.9±7.1 vs. 0.2±0.02 g/day/1.73 m 2 ) improved significantly (P<0.05). Kaplan-Meier analysis showed a cumulative 10-yr renal relapse-free survival of 73.3% when considering relapses with severe proteinuria. Cumulative probability that hospitalization would not be required was 93.8% at 1-yr and 71.4% at 10-yr. Conclusion: Our multi-targeted induction and maintenance protocol for treatment in children with severe proliferative LN resulted in good longterm patient survival and renal preservation, with a good safety profile. Objective: To determine relative changes in blood pressure between Aboriginal and non-Aboriginal children as they move through adolescence into young adulthood. Background: Hypertension is associated with increased risk of chronic kidney disease (CKD) in adulthood. Aboriginal children have a higher prevalence of overweight/obesity, a known risk factor for hypertension in adolescence. Methods: A prospective cohort study of Aboriginal and non-Aboriginal school children commenced in 2002 across 15 different screening centers involving 38 primary schools and 213 high schools across urban, regional and remote NSW. Blood pressure, BMI and urinalysis were measured every 2 years. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were standardized for sex, age and height. We fitted a series of mixed linear regression models adjusting for age, sex, BMI SDS, Aboriginality, birth weight and socioeconomic status (SES). Results: 3418 (1949 Aboriginal) participants were screened over a total of 11 years follow up. At baseline, the prevalence of systolic hypertension (SBP SDS >95 th centile) was 7.2% (mean age 11 yr) which increased to 15.4% at 8-yr follow up. The prevalence of diastolic hypertension remained relatively unchanged at 3.1% and 2.9% at baseline and 8-yr follow up respectively. Multivariate analysis showed mean SBP SDS increased with increasing age (0.06 SDS per yr of age, P<0.01) but there was no significant difference in SBP between Aboriginal and nonAboriginal children. Low birth weight was significantly associated with an increase in mean SBP (0.12 SDS, P=0.01) as was increasing BMI (0.31 SDS per 1 unit increase in BMI SDS, P<0.01). Lower SES was associated with increasing SBP (<25 th quartile: 0.20 SDS, P <0.01). A similar effect of increasing age (0.03 SDS per yr of age, P<0.01) and BMI (0.14 SDS per 1 unit increase in BMI SDS, P<0.01) was seen for DBP, whilst lower SES was associated with a lower DBP (<25 th quartile: -0.12 SDS, P<0.01). The mean DBP was not significantly different between Aboriginal and non-Aboriginal children.
Conclusions: Increasing BMI remains the greatest modifiable risk factor for SBP and DBP, with prevention of low birth weight and improving SES also important to reduce cardiovascular risk in children and adolescents.
Screening of hypertension in school going children of Dhaka and its downtown in Bangladesh
Md AH Khan, ANM Saiful Hasan Department of Pediatric Nephrology, National Institute of Kidney Diseases and Urology (NIKDU), Dhaka, Bangladesh
Background: Hypertension is an important cause of morbidity and mortality and childhood hypertension is the predictor of adult hypertension. Different studies worldwide documented that hypertension may begin in adolescent and perhaps even in childhood. The purpose of this study was to screen hypertension and its risk factors among school going children in Dhaka and its downtown. Methods: School going children aged between 4-16 yr, of five schools were selected randomly and blood pressure (BP) measurements were taken by mercury sphygmomanometer. Hypertension was considered as BP more than 95 th percentile by age and sex. BP was recorded among 1682 children. Children were screened for hematuria and proteinuria. Dietary history and family history of hypertension was recorded. Results: Total children having hypertension was 43 (2.6%); male (2.8%) and female (2.2%). One boy had hypertension, proteinuria and hematuria; 5 patients (0.3%) had hypertension with proteinuria and 5 (0.3%) had hypertension with hematuria. Among hypertensive children 13 (30.2%) had family history of hypertension. 1495 (88.9%) had come from lower and lower middle socioeconomic condition. 5 (0.3%) were underweight with hypertension and 7 (0.4%) had stunting with hypertension. Conclusion: We found that prevalence of hypertension was 2.6% diagnosed only after screening. So, for the prevention of complications of hypertension every child should be screened for hypertension and remain under follow up.
Hypertension prevalence and risk factors in children and adolescents of school-going age in the Phoenix Area, Durban, South Africa Introduction: Hypertension is a leading cause of morbidity and mortality in adults, but few studies have presented the significance of the prevalence of pre-hypertension and hypertension in school-going populations. Objective: The objective of this study was to determine the prevalence of hypertension, and define its contributing risk factors in children and adolescents of school-going age within an urban community in Durban, South Africa. Methods: A cross-sectional assessment of blood pressure was conducted in the central Phoenix region, KwaZulu-Natal, South Africa in 2012. Initial measurements of the 423 children and adolescents (ages 6-18 years) included height, weight, and waist circumference and oscillometric blood pressure readings. Furthermore, demographic information, factors of lifestyle, medical and family history of suspected risk factors as well as biochemical measurements of blood glucose, triglycerides and HDL cholesterol levels were obtained by finger prick testing to describe their significance on influencing blood pressure. Results: The prevalence of pre-hypertension and hypertension amongst school going children in the central Phoenix area in Durban, South Africa is estimated to be 2.1% (0.8-3.5%) and 2.6% (1.1-4.1%) respectively, similar to the 3-5% indicated in the literature. The risk of high blood pressure was found to rise with an increase in age, weight, height, waist circumference, increased triglyceride levels and heart rate, family history of high blood pressure and diabetes and suspected substance abuse. Lack of exercise and consumption of soft drinks were associated with increased risk for hypertension; probably related to high BMI associated with lifestyle factors. Conclusions: Given the prevalence of the disease in the community, the fact that the condition is undetected as well as long-term sequelae with respect to target-organ damage, this study will help inform authorities in making recommendations on the evaluation and management of high blood pressure in the young in developing countries.
Nephrotic syndrome
Randomized controlled trial to compare the efficacy and safety of mycophenolate mofetil versus levamisole in children with frequently relapsing and steroid dependent nephrotic syndrome Methods: Following written consent, consecutive patients with steroid sensitive NS, 6-18 yr-old, with frequent relapses or steroid dependence in the preceding six months are randomized to receive oral levamisole (2-2.5 mg/kg on alternate days) or MMF (800-1000 mg/m 2 daily) for 12-months, while stratifying for disease severity and ensuring allocation concealment. Therapy with prednisolone is tapered & discontinued at 4 months; relapses are treated with prednisolone 2 mg/kg/d until remission, followed by 1.5 mg/kg/d for 4-wk.The relative proportions of T and B lymphocyte subsets is compared at baseline and during therapy in a subset of consecutive patients randomized to either arm. Outcomes, based on intention-to-treat analysis at 12 months of therapy, include the frequency of relapses, the proportions in sustained remission and frequent relapses, the time to first relapse, the cumulative prednisolone requirement, the types & number of adverse effects, the types & rates of infections in the groups, and the growth and growth velocity. Assuming that therapy with MMF shall reduce relapse rates by 40% over the relapse rates observed during therapy with levamisole, 66 patients are required in each group at a power of 80% and two-tailed alpha error of 0.05, while allowing for 10% loss of follow up. Results: Baseline characteristics of 146 patients (123 boys) randomized, including 44 with steroid dependence are presented. Conclusions: Randomization into the study was completed in September 2013 and analysis of 1-yr outcomes is due in August 2014. Results of the study shall have implications for guiding the choice of corticosteroid sparing agents in patients with frequent relapses.
Effect of zinc supplements in reducing relapses among steroid sensitive nephrotic syndrome and steroid dependent nephrotic syndrome in children, a randomized double blind placebo control study Objective: To determine the effect of zinc supplements in reducing relapse rates in steroid-dependent (SDNS) and steroid-sensitive (SSNS) nephrotic syndrome. Methods: A randomized, double-blind, placebo control study done at the outpatient section of our Institute from May 2010-January 2013. 34 pediatric patients with steroid-sensitive (SSNS) or steroid-dependent nephrotic syndrome (SDNS) were divided into two arms: those who received zinc supplementation at the recommended daily allowance for age and those who received placebo. Monthly urinalysis and follow up were done for 6 months. The incidence of relapse at 3 and 6 months of placebo/zinc supplementation as well as the incidence of infection rate during episodes of relapse was determined. Results: More than half of the patients were children with SSNS. Baseline characteristics were similar in both groups. Patients who received zinc showed fewer relapse at 6 months' treatment. Patients who received zinc had higher likelihood of achieving remission compared to the placebo. Relapses occurring at 3 and 6 months of zinc/placebo supplementation were associated with infections. Conclusion: There was no significant difference in the mean relapse rates at 3 months of therapy with either zinc or placebo; after 6 months there was significant decrease in the mean relapses among patients using Zinc. Patients receiving zinc had higher likelihood of achieving sustained remissions. Relapses occurring at 3 and 6 months of zinc/placebo supplementation are associated with the incidence of infection. Nephrotic children have an increased susceptibility to infections due to a defect in Tlymphocyte function. These infections may result in relapses and poor response to steroid therapy. Zinc supplementation is proposed to augment gene expression in the activation of T lymphocytes, resulting in decreased incidence of infection. Objective: CD80/B7-1 (a T cell co-stimulatory molecule expressed on antigen presenting cells) expression was induced in the podocytes in genetic, bacterial toxin and drug induced experimental models of proteinuria in mice. Subsequently, CD80 expression was also detected in the podocytes of patients with Minimal change disease (MCD) and elevated secretion of CD80 was detected in the urine of these patients during an active episode of the disease. The objective of this study is to understand the mechanisms and signaling pathways which lead to elevated levels of CD80 in the podocytes and the consequences of these elevated levels at the molecular level, specifically looking at the disruption of the slit diaphragm which forms the final barrier to urinary protein loss. Methods: Serum from LPS treated mice is added to podocytes followed by RT-PCR to detect CD80 induction in the podocytes. Podocyte cell lines stably expressing CD80 were generated and various techniques including immunoblotting, immunofluorescence microscopy, RT-PCR analysis, co-immunoprecipitation were used to look for changes in expression and localization of slit diaphragm (SD) proteins. Results and Conclusions: There was no major change in the absolute levels of podocyte proteins in presence of CD80. Therefore effects of CD80 could be at the level of causing mislocalization or sequestration of SD proteins. Preliminary data indicates possible interaction of Neph 1 with CD80, which could prevent interactions with endogenous proteins essential for maintaining the SD structure. Serum from LPS treated wild type and CD80 -/-mice both induced CD80 in cultured podocytes, on the other hand serum from LPS treated mice defective in TLR4 (receptor for LPS) signaling did not induce CD80 on podocytes suggesting that a soluble factor downstream of TLR4 signaling is involved in inflammation induced proteinuria.
Quantitation of serum and urine angiopoietin-like 3 and 4 in children with nephrotic syndrome R. Dai, H. Xu, G. Li, H. Liu, Y. Zhai Department of Nephrology and Rheumatology, Children's Hospital of Fudan University, Shanghai, China Objectives: Studies have explored several circulating or podocytesecreted proteins, such as the angiopoietin-like-4 (Angptl4) which results in damage to the glomerular filtration barrier via an autocrine or paracrine pathway. Studies have shown that Angptl3, a homologue of Angptl4, is a secreted protein. The aim of this study is to quantify the serum and urine ANGPTL3 and 4 levels in children with nephrotic syndrome (NS). Methods: Serum and urine ANGPTL3 concentration were detected by ELISA. Results: Serum and urine samples (n=280) of 180 children (age 6±4yr) with NS were analyzed. The average serum concentration of ANGPTL3 was 713.94±432.65 ng/ml [higher than healthy children 308.20 ± 87.93 ng/ml], and of ANGPTL433.32±57.71 ng/ml, similar to healthy children. Urine concentration of ANGPTL3 was 1.94±1.97 ng/ml (similar to healthy children) and of ANGPTL4 0.18 ± 0.07 ng/ml [higher than healthy children 0.02±0.01 ng/ml, n=18]. ANGPTL3 serum level was positively correlated with 24-hr urine protein excretion (P=0.004), Up/ Ucr (P=0.006), triglyceride (P=0.021), and cholesterol (P=0.001), but not with creatinine (P=0.477) or BUN (P=0.717); ANGPTL4 urine levels was positively correlated with Up/Ucr (r=0.318, P=0.01); ANGPTL3 urine levels and ANGPTL4 serum levels had no difference with all the selected clinical parameters. Serum ANGPTL3 level varied in different conditions: minimal change disease (438.35±200.61 ng/ml), FSGS (678.35±361.67 ng/ml), membranous nephropathy (343.51±169.85 ng/ ml), mesangial proliferative glomerulonephritis (1112.39±446.53 ng/ml) and membranoproliferative glomerulonephritis (489.31±247.76 ng/ml). ANGPTL3 serum levels may indicate the degree of proteinuria in NS and not be affected by lipid levels. In terms of treatment response, no difference of serum and urine ANGPTL3 and 4 levels were found among steroid sensitive, steroid-resistant, or steroid-dependent NS group, as well as between the frequently relapsing and infrequently elapsing group. Conclusions: Our data showed that serum ANGPTL3 level and urine ANGPTL4 level were elevated in children with NS. Serum ANGPTL3 level was positively related to proteinuria and serum lipid level in NS. Urine ANGPTL4 level correlated with proteinuria. Objectives: Rituximab is increasingly used in nephrotic children with FSGS who failed conventional immunosuppressive therapy. The effect of rituximab, however, is not sustained especially post-B-cell recovery. This study aimed to determine the immunological markers that predict relapse in rituximab-treated FSGS patients with complete response. Methods: 15 FSGS nephrotic children (median age 15 yr, duration of follow-up 7.4-32.8 months) treated with rituximab were studied. Urinary/ blood biochemical parameters and 31 T-and B-cell subsets were monitored at day 0, day 14, 3 and 6 months and at relapse. Complete responders to rituximab were defined as urine protein: creatinine ratio <0.02 g/mmol and ability to wean off steroids and calcineurin inhibitors within 3 months. Statistical analysis was performed using Mann-Whitney U test and receiver-operating curve (ROC) analysis. Results: CD19+ subset was significantly decreased in all patients postrituximab (11.57±1.36% vs. 0.23±0.06%, P<0.001). Nine (60%) patients achieved complete response with 7/9 (78%) eventually relapsing (duration of remission: 262-484 days). All patients who relapsed had B-cell recovery. Amongst the various immunological subsets, ICOS+CD8+ CD3+ and FAS+ICOS+CD8+ cells at day 0 were predictive of relapse within 300 days of rituximab therapy (R<300). Mean ICOS+CD8+CD3+ of R<300 group was 1.24±0.37% compared to 0.15±0.06% in non-R<300 group (P=0.04), whereas mean FAS+ICOS+CD8+ of R<300 group was 0.70±0.06% compared to 0.14±0.06% in non-R<300 group (P=0.037). ROC analysis revealed an area under curve of 1.00 (95% CI: 1.00-1.00, P=0.027) for both markers. Using a threshold subset value of >0.64% for ICOS+CD8+CD3+ and >0.52% for FAS+ICOS+CD8+ cells yielded a sensitivity and specificity of 1for predicting relapse within 300 days of rituximab therapy for both markers. Conclusions: Our study illustrated the potential utilization of ICOS+ CD8+CD3+ and FAS+ICOS+CD8+ as predictive markers of relapse within 300 days of rituximab therapy, possibly providing a guide for further rituximab dosing following B-cell recovery but prior to clinical relapse. Objective: Cyclosporine (CsA) is a well-established treatment for steroid-dependent nephrotic syndrome (SDNS) and steroid-resistant nephrotic syndrome (SRNS), with high-grade evidence. However, chronic CsA nephrotoxicity (CsAN), including tubulointerstitial and vascular lesions is a major concern, especially with long-term use. Previous reports suggest that it is related to long-term CsA administration, frequent relapses during CsA treatment, and higher CsA trough levels, but it has seldom been assessed in large numbers of patients. We evaluated the risk factors for CsAN in children with idiopathic NS receiving CsA treatment. Methods: We retrospectively evaluated medical records and renal pathology of 83 patients (56 male and 27 female) with idiopathic NS who were treated with long-term CsA for >6 months (mean 34.8 months, range 8-128 months) and underwent biopsy between January 2005 and January 2014. Thirty-six patients started CsA because of SRNS, but all of them had become steroid sensitive at the last observation. CsA treatment was continued without intermission until biopsy in all patients. CsAN was defined as the presence of tubulointerstitial lesions and/or CsAassociated arteriolar hyalinosis. We evaluated the risk factors for CsAN with regard to 11 clinical and laboratory factors (sex, age of NS onset, age at biopsy, histological findings, past history of SRNS, duration of NS, number of relapses, duration of CsA treatment, number of relapses on CsA treatment, 2-hour CsA concentration (C2), and angiotensinconverting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) treatment for >6 months, by univariate and multivariate analysis. Results: CsA-associated arteriolopathy was observed in 34 patients (41%) and tubulointerstitial lesions in 31 patients (37%). Sex, age at renal biopsy, duration of NS, duration of CsA treatment, number of relapse on CsA treatment and use of ACEIs/ARBs were positively associated with CsA associated arteriolopathy by univariate analysis and only use of ACEIs/ARBs was independent risk factor by multivariate analysis [P=0.03, odds ratio (OR): 5.45, 95% CI: 1.2-28.0]. On the other hand, age at biopsy, histological findings, CsA C2 and use of ACEIs/ARBs were positively associated with tubulointerstitial lesion by univariate analysis and CsA C2 (>502.1 ng/ml, P=0.003, OR: 22.7, 95% CI: 2.7-533.6) and age at biopsy (>9.9 years, P=0.04, OR: 14.37, 95% CI, 1.1-588.0) were independent risk factors by multivariate analysis. Conclusions: The use of ACEIs/ARBs, C2 and age at biopsy were independent, significant risk factors for CsAN in children with NS. Combination treatment with CsA and ACEI/ARB should be avoided if possible. Objective: The objective of the study was to determine if real-time polymerase chain reaction and high resolution melt (HRM) curve analysis could be used as a screening tool to identify for variants in the Wilms tumor 1 (WT1) gene in comparison to DNA Sanger sequencing. Methods: HRM assay for the analysis of exons 8 and 9 of the WT1 gene were designed, and optimized. Stringent criteria were employed for primer designing in order to enable reproducible detection of variants within the amplicon. HRM analysis for exons 8 and 9 of the WT1 gene in a final set of 60 genomic DNA samples (5 samples for standardization, 55 samples for validation, including 10 blinded samples) were performed under identical amplification conditions. Results: After the initial standardization, WT1 exons 8 and 9 displayed unique melt curve profiles that were reproducible. A blinded assessment was performed on 10 samples for validation of the HRM technique as compared to sequencing. A 100% specificity and sensitivity was observed for prediction of normal variants when compared with the Sanger's sequencing. Similar results were obtained during the subsequent analysis of the remaining 45 samples. Both the techniques did not reveal any abnormal pathogenic variant. The screening result using HRM was obtained in 2 hours 15 minutes, while sequencing required a minimum of 5 days. Conclusion: Although sequencing is the gold standard for detecting variants, it involves additional steps and requires a more turnaround time as compared to HRM. Our results showed that HRM could be used as a robust screening technique to detect abnormal variants, which could be further sequenced, to determine the precise variation. HRM curve analysis is a quick, reliable and a high throughput post-PCR method to analyze genetic mutations or variances in nucleic acid sequences. Since HRM is a closed tube method, it eliminates the possibility of template contamination. The characteristics of HRM such as its simplicity ease of use, low cost, high sensitivity, and specificity, makes it an efficient tool for sequence variant detection.
The study of urinary CD80 in children with minimal change disease and focal segmental glomerulosclerosis L. Chen, L. Xiaorong, S. Ying, C. Zhi, F. Jianfeng, J. Yeping, M. Qun Department of Nephrology, Beijing Children's Hospital affiliated to Capital Medical University, Beijing, PR China Background: Early diagnosis of minimal change disease (MCD) in nephrotic syndrome (NS) patients remains challenging. CD80, a transmembrane protein, is present on podocytes in a number of experimental models of NS. Urinary CD80 levels are significantly elevated in MCD but not in focal segmental glomerulosclerosis (FSGS) or other glomerulopathies. The purpose of this study was to investigate the feasibility of using urinary CD80 levels as a biomarker for diagnosis of MCD. Methods: The clinical data and morning urine samples have been collected from 37 patients with MCD, 27 patients with FSGS, 30 patients with other glomerulopathies who underwent renal biopsy. 71 healthy controls were included. ELISA was used to determine urine CD80 concentration. CD80 concentration between MCD, FSGS, other glomerulopathies and control group were compared. The receiver operating characteristic curve (ROC) analysis was used to determine the cut-off point of urinary CD80 as a biological marker for the diagnosis of MCD. Results: The concentration of urinary CD80 was significantly higher in the active MCD group (689.66±378.21 ng/g creat) than FSGS [48.28 (10.36, 163 .94) ng/g creat], other glomerulopathies [52.20 (11.41, 249 .75) ng/g creat] and controls (81.83±23.01 ng/g creat); P value <0.001 in all. A cut-off value of 328.98 (ng/g creat) was proposed, with sensitivity of 81.1% and specificity of 94.4%. The area under the ROC curve was 0.925 (95% CI: 0.87-0.98). Urinary CD80 was elevated in three patients with tip lesion and one with NOS. Mean value was 334.58 ±208.92 ng/g creat in the patients with tip lesion and 38. 54(5.36, 80.16) ng/g creat in NOS. Urinary CD80 was higher in tip lesions than in NOS (P <0.05). Urinary CD80 was elevated in two patients with IgA nephropathy and one patient with lupus nephritis. Conclusions: Urine CD80 increased significantly in children with MCD, and can be used as a biomarker to identify MCD with FSGS.
A randomized controlled trial to assess the effect of calcium and vitamin D supplementation on bone biochemistry and bone mineral density in pediatric steroid sensitive nephrotic syndrome S. Banerjee, S. Basu, J. Sengupta Institute of Child Health, Kolkata
Objectives: Low vitamin D levels, osteoporosis and hypercalciuria are known complications of nephrotic syndrome (NS) and its treatment. The aim is to assess whether supplementation with vitamin D and calcium after relapse protects against hypovitaminosis and maintains bone mineral density (BMD) over 6 months.
Methods:
A randomized controlled open label trial was designed, with 30 patients in each arm to yield over 90% power. Children (2-10 yr) presenting in active NS relapse are being recruited. Standard treatment of NS is continued. Centralized computer randomisation is followed to allot patients into test group or control group. The test group receives vitamin D and calcium supplementation. Levels of serum creatinine, albumin, calcium, phosphate, alkaline phosphatase, and 25-hydroxycholecalciferol [25(OH)D]; urine protein/creatinine and calcium/ creatinine ratios are documented at study entry, 1 month and 6 months. In addition 25(OH)D levels are assessed in case of interim relapse and further supplementation given to optimize levels if required. Ultrasound of the renal tract and lumbar BMD are performed at study entry and at 6 months. At study completion, vitamin D levels and difference in lumbar BMD will be compared between groups and assessed for any correlation with number of interim relapses and cumulative steroid therapy. Results: This is an ongoing study and till date, 28 patients have undergone randomization. Twenty children have completed the study, 9 in the test group and 11 in the control group. Their mean age is 4.9 years, 6 are female, 12 had a first episode of NS or have infrequent relapses, whereas 8 have frequent relapses or are steroid dependent. The mean vitamin D level at recruitment was 7.7ng/ml, and mean lumbar BMD was 0.52gm/ cm 2 .The mean difference over 6 months in 25(OH)D levels was + 22.95ng/dl in the test group and +1.47ng/ml in the control group, while mean difference in BMD was +11% and +3.4% respectively. None of the children in either group had hypercalciuria or nephrocalcinosis. Conclusions: On study completion we expect to understand whether calcium and vitamin D supplementation improves serum vitamin D levels and maintains BMD in children with NS, in the short term. This will help in formulating definitive guidelines for the requirement of such supplements, in this chronically relapsing disease. Objectives: Abnormal expression and gain of function of TRPC6 were involved in the pathogenesis of hereditary and nonhereditary forms of renal diseases. Although underlying molecular mechanisms of this remain poorly understood, recent research found that there were many cell signaling pathways involved in regulating the expression and function of TRPC6. The purpose of our study is to examine the effect of distinct mammalian target of rapamycin complex (mTORC1 or mTORC2) signaling pathway on TRPC6 in podocytes. Methods: We applied pharmacological inhibitors of mTOR and siRNA specific for component of mTOR to explore mTOR signaling to regulate TRPC6 in podocytes. Podocytes were exposed to rapamycin, an inhibitor of mTORC1 signaling pathway, and ku0063794, a dual inhibitor of mTORC1 and mTORC2. In addition, using specific siRNA knocked down the component of mTORC1 raptor and the component of mTORC2 rictor. By using real-time reverse transcription PCR and western blotting, mRNA and protein expression of TRPC6 were examined. Also, fluorescence calcium imaging was used to study the function of TRPC6 in podocytes. Results: Rapamycin has no effect on mRNA and protein expression levels of TRPC6 at different time points and concentrations. Ku0063794 could down-regulate mRNA and protein of TRPC6 in podocytes. In addition, ku0063794, but not rapamycin suppressed TRPC6-dependent intracellular calcium influx. Furthermore, while knockdown of rictor suppressed TRPC6 protein expression and TRPC6-dependent calcium influx into podocytes, knockdown of raptor didn't change the above. Conclusions: These findings indicate that mTORC2 signaling pathway regulates TRPC6 in podocytes, while mTORC1 signaling pathway may have no effect on TRPC6. Objectives: Expression of CD80 (a T cell costimulatory molecule) is induced in LPS, PAN and α3-/-mouse models of podocyte injury (Reiser et al. 2004) . Proteinuria in response to LPS is not observed in CD80-/-mice which show that CD80 induction is important in LPS-mediated podocyte injury. The objective of our study is to understand the role of CD80 in podocyte disease biology. Methods: Podocyte cell lines which stably express C-terminus Myctagged CD80 were generated by transfection and cell sorting to study the role of CD80 expression in podocytes. By confocal microscopy, the CD80+ and wild type (wt) podocytes were compared for changes in the actin morphology to see if CD80 expression alone can cause actin derangement in the cells. Reverse Transcriptase PCR and western blot analysis were done to compare CD80+ and wt podocytes for differences in the expression of important proteins to check if CD80 expression affects the expression of SD and other important podocyte proteins. By monitoring the total cell count of CD80+ and wt podocytes in culture, the growth curves of CD80+ and wt podocytes were compared to see if CD80 affects cell division and/or cell death. To understand the mechanism by which CD80 may be mediating podocyte injury, we are trying to find CD80-interacting podocyte proteins by CoIP and pull down assays. We also examined the interaction of CD80 with major SD proteins by transfection and CoIP studies in a heterologous system i.e. HEK293. Results: Podocyte cell line stably expressing high levels of CD80 were generated. The CD80+ podocytes were similar to the wt podocytes in the actin morphology, in the expression levels of major SD proteins and in the growth curve. In trying to find out CD80-interacting proteins, we have found a novel interaction of CD80 and Neph1 by transfecting the two proteins in a heterologous system and doing a CoIP. Conclusions: The expression of CD80 alone in the podocytes does not cause actin derangement and does not affect the expression levels of major SD and podocyte proteins. CD80 expression causes no change in cell growth and/or death. CD80 may mediate its effects by its interaction with Neph1. The possible mechanism by which CD80-Neph1 interaction affects downstream podocyte SD signaling is under investigation. syndrome and adriamycin-induced nephropathy rats. The aim of this study is to investigate the impact of Angptl3 knock-out on LPS-induced nephropathy mice. Methods: LPS-induced nephropathy model was established in B6; 129Sv-Angptl3+/+and B6; 129Sv-Angptl3-/-mice by intraperitoneal injection of 13μg/kg LPS. Serum albumin, serum lipid levels, and urine albumin were examined by automatic chemical analyzer. Renal pathologic analysis, including light microscopy and electron microscopy were performed. Results: Urine protein was negative in both B6; 129Sv-Angptl3-/-mice and B6; 129Sv-Angptl3+/+mice. B6; 129Sv-Angptl3-/-mice had normal serum albumin as B6; 129Sv-Angptl3+/+mice (29.85±0.71 vs. 28.75 ±0.41 g/L, P>0.05), but B6; 129Sv-Angptl3-/-mice had lower cholesterol and triglycerides compared to B6; 129Sv-Angptl3+/+mice (cholesterol 1.82±0.15 vs. 2.86±0.13 mmol/L, P<0.05; triglyceride 0.48±0.02 vs. 0.87 ±0.12 mmol/L, P<0.05). Light and electron microscopy showed no difference in histology in B6; 129Sv-Angptl3-/-& B6; 129Sv-Angptl3+/+mice. In LPS-induced nephropathy model, 30 hours after injection of LPS, B6; 129Sv-Angptl3+/+mice had significant proteinuria (32.03±0.48 mg/mmol), hypoalbuminemia (23.61±1.19 g/L) and hypercholesterolemia (3.45±0.29 mmol/L). The urinary albumin creatinine ratio in B6; 129Sv-Angptl3+/+mice was nearly 2 folds higher than that in B6; 129Sv-Angptl3-/-mice (32.03±0.48 vs. 17.31±3.21 mg/mmol P <0.05), though both had low serum albumin level (23.61±1.19 vs. KO 22.14±1.31g/L, P >0.05). Serum cholesterol in B6; 129Sv-Angptl3+/+ mice was significantly higher (3.45±0.29 vs. 1.59±0.33 mmol/L). Light microscopy showed no difference between two groups; electron microscopy showed severe injury of podocytes in Angptl3+/+mice, and no manifestation of podocyte injury in Angptl3-/-mice 30 hr after LPS injection. Conclusions: Angptl3 knock-out can significantly attenuate proteinuria and prevent hypercholesterolemia in mice after LPS injection, which indicate that Angptl3 might be related to podocyte injury. Reduction of Angptl3 expression might be a potential way to decrease proteinuria in nephrotic syndrome. Objectives: To explore the major causative genes, and to establish screening strategies of causative genes in children with NS. Methods: NPHS1, NPHS2, PLCE1, LAMB2, LMX1B, COQ2 and WT1 genes were tested in patients with congenital NS while NPHS1, NPHS2, PLCE1 and WT1 were tested in patients with infantile NS by direct sequencing. In early-and late-onset NS group and familial AR, we tested NPHS2 and WT1 by direct sequencing, as well as 42 common gene mutations involved in 8 main genes by Snapshot analysis. ACTN4, TRPC6 and INF2 were tested in familial AD group. Whole exon sequencing (WES) was done when no causative mutation was found in familial forms. Results: Causative mutations of NPHS1 were found in 8; no other mutation was found in CNS (n=10). Among the 12 cases with infantile NS, 6 had mutations in WT1 (n=3), NPHS2 (n=2) and NPHS1 (n=1) mutations, respectively. In 32 cases of initial SRNS 6 had mutations in WT1 (n=3), NPHS2 (n=2) and INF2 (n=1). In 19 cases of later SRNS children, one had mutation of NPHS1 gene. In 42 cases of frequent relapsing SSNS children, one had mutation of NPHS1 gene. There were no causative mutations detected among 84 cases of delayed onset NS children. In two AR-NS pedigrees, we found one pedigree with NPHS2 mutation, while no mutation of NPHS2 and WT1was found in other pedigree, no causative genes were found by WES analysis. In an AD-NS family, all the patients were found had INF2 deletion mutation. Conclusions: NPHS1 is the main causative gene in CNS children, so NPHS1 analysis is recommended. It is recommended to test WT1 and NPHS2 in children of infantile NS. In children of early-onset NS, 18.8% presented related genetic mutations. Among initial SRNS, the major genes were WT1 and NPHS2, testing for these genes is recommended. In children of delayed-onset NS, it is not suggested to analyze gene mutation. NPHS2 and INF2 were causative genes of AR-NS and AD-NS, respectively, and analysis of NPHS2 and INF2 was recommended in families with AR-NS and AD-NS.
Influence of tacrolimus on expression and distribution of TRPC6 in podocytes
Zhang-Yao, Ma-yuanyuan, Yuli, Yu-shengyou Department of Pediatrics, Guangzhou First People's Hospital, Affiliated to Guangzhou Medical University, Guangdong, 510180, China
Objective: By observing the expression and distribution changes of transient receptor potential cation channel protein 6 (TRPC6) in glomerular podocytes after puromycin (PAN) stimulation and the following tacrolimus (FK506) intervention, this study investigated the protective effect of FK506 in podocytes and the correlation of TRPC6 with podocyte injury repair. Methods: MPC5 were cultured in vitro, paralleled with the control group, PAN stimulation group, and FK506 intervention group. The control group was cultured in RPMI 1640; PAN stimulation group was added PAN to stimulate Mouse podocyte cell line (MPC5), and FK506 intervention group was added with PAN and FK506 simultaneously, then observed cell morphology and collected the cells at 8h, 24h and 48h, respectively. The experiments were further assayed the activity of podocytes using the MTT method and the apoptosis rate with flow cytometry, also detected TRPC6 mRNA and protein expression by RT-PCR and Western blot, and then observed the distribution of TRPC6 with indirect immunofluorescence labeling under confocal microscope. Results: After PAN stimulation, the cell bodies of podocytes were significantly reduced, the foot processes showed retraction and the intercellular junctions were lost. At 24-h and 48-h the activities of podocytes were significantly lower, apoptosis rate were increased, TRPC6 mRNA and protein expression were significantly increased when compared with control group; the distribution of TRPC6 was apparently different from the control group. After FK506 intervention, the cell bodies were bigger than in PAN group, most cells maintain normal foot processes; the activities of podocytes significantly increased after FK506 intervention for 24-h and 48-h and the apoptosis rate was markedly lower than that of PAN stimulation group. Conclusion: FK506 can directly act on the podocytes to inhibit PANinduced damage on podocyte structure and reduce the apoptosis rate of podocytes, which may be related to stabilizing TRPC6 expression and distribution in podocytes by FK506, thus maintaining structure and function integrality of slit diaphragm (SD), and playing a role in protecting podocytes and resulting in antiproteinuric effects.
Dexamethasone inhibits glomerular podocyte apoptosis by stabilizing the PI3K/Akt signal pathway Yu-li, Yu-shengyou, Hao-zhihong, Zhang-yao Department of Pediatrics, Guangzhou First People's Hospital, Affiliated to Guangzhou Medical University, Guangdong, China Dexamethasone (DEX) is an established treatment for glomerular disease that, at least in part, protects podocyes from apoptotic death. To reveal the molecular mechanisms for renal protection, we examined the role of the PI3K/Akt signal pathway in DEX-mediated inhibition of podocyte apoptosis. A mouse podocyte cell line was treated with vehicle (DMSO), the apoptosis inducer puromycin (PAN), DEX + PAN, or DEX + PAN following pretreatment with the PI3K inhibitor LY294002. Western blotting, RT-PCR, and immunocytochemistry under laser confocal microscopy were adopted to measure the expression and subcellular distribution of CD2AP, a major regulator of cytoskeletal dynamics and podocyte morphology, at both the mRNA and protein levels, as well as the colocalization of CD2AP protein with the PI3K regulatory subunit p85. Western blotting was also used to detect changes in expression of Akt, pAkt, GSK3β, and p-GSK3β. Podocyte apoptosis was measured by flow cytometry. The expression of CD2AP mRNA and protein decreased significantly during PAN treatment (P<0.05). The subcellular distribution of CD2AP protein changed from evenly distributed filaments in cytoplasmic foot processes and the nucleus to discontinuous rough granules in the perinuclear region. In addition, CD2AP was aberrantly co-localization with p85. Normal CD2AP mRNA expression and subcellular protein distribution were maintained in the PAN + DEX group, and DEX coapplication also reduced CD2AP−p85 co-localization. PAN evoked a concentration-dependent decrease in p-Akt and p-GSK3β expression (P<0.05), with p-Akt expression reaching a nadir at 15 min and p-GSK3β expression at 30 min. DEX treatment induced a concentrationdependent reversal of PAN-induced p-Akt and p-GSK3β downregulation (P<0.05). The PI3K inhibitor LY294002 blocked p-Akt and p-GSK3β expression in podocytes (P<0.01). Cells treated with PAN exhibited a significantly higher apoptosis rate than untreated or vehicle-treated cells (P<0.05). Furthermore, LY294002 exacerbated PAN-induced apoptosis (P<0.01). DEX treatment caused a concentration dependent decrease in PAN induced apoptosis (P<0.05). DEX protects podocytes by stabilizing the expression and subcellular distribution of CD2AP and maintaining expression of phosphor-activated Akt and GSK3β. Objectives: KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease) is a nation-wide, 10-yr longitudinal cohort study collecting information of Korean chronic kidney disease (CKD) patients, launched in 2011, to assess the characteristics and risk factors of progression and complications of CKD. Pediatric sub-cohort of KNOW-CKD is planned to enroll 400 children with CKD, stage I to V (predialysis), and collect information for >5 yr. Here we report the third-year follow-up report of pediatric sub-cohort, KNOW-Ped CKD. Methods: Five major pediatric nephrology centers of Korea enrolled children with CKD. After informed consent, medical history taking, questionnaire assessment of socio-economic status, anthropometric measurement, and clinical assessment using laboratory and imaging tests were done and recorded using web-based case report form. Results: Total 300 patients (M: F 199:101) were enrolled by Feb. 2014. Average age was 10.01 yr. Etiologies of CKD were congenital renal dysplasia (48%), reflux nephropathy/chronic pyelonephritis (22%), primary glomerular diseases (16%), secondary glomerular diseases (5%), and others. Stages of CKD were I for 16%, II 18%, III 34%, IV 18%, and V 15%. Age groups were less than 2 yr for 10%, 2 to 5 yr for 15%, 6 to 11 yr 28%, and 12 to 19 yr 47%. One third had histories of UTI and 9% had developmental delay. Growth delay was observed even in early stage of CKD stage, with mean height and weight Z score of -0.98 and 0.99, especially younger (<6 yr) with advanced CKD (IVand V). Hypertension was observed in 16% and left ventricular hypertrophy in 9% of the patients. One-year follow-up data were available in 230 patients; renal replacement therapy was introduced in 33(14%) and other 5 (2 %) experienced doubling of Cr. Conclusion: This prospective, multicenter cohort study aiming to improve CKD outcome revealed that our current management of pediatric CKD in Korea had room for improvement. We expect to obtain more information on pediatric CKD with this cohort study.
An on-line registry of hereditary kidney diseases in children in China F. Wang, J. Ding, H.W Zhang, X.Y. Liu, Y.Q. Zhang, W. Li Department of Pediatrics, Peking University First Hospital, Beijing, P. R. China A paper record of patients with rare hereditary renal diseases had been kept and maintained for about 20 years in Department of Pediatrics, Peking University First Hospital. However, this system was insufficient as records for conducting research and for engaging more sites. An online system will make any data extraction and analysis for research much easier, and be convenient for a greater number of centres (other than Peking First University) to start collecting information on patients with rare kidney diseases. Supported by a grant from "Twelfth Five-Year" Science and Technology Support Project in China, an online registry was developed in 2012. Its language is Chinese. To design the registry, well-established and successful registries such as ASTOR (Alport Syndrome Treatments and Outcomes Registry) were referred. All IT support was provided by the IT company that developed the registry database. The registry initially developed as a single-site registry at Peking First Hospital, now has been expanded as part of a national collaboration with 6 centres in 6 cities in China (Beijing, Hangzhou, Changsha, Guangzhou, Fuzhou and Chongqing). Training for using the registry in each centre had been performed 10 months ago. Each centre accesses to the registry via a unique Username and Password. Only those individuals who involved in updating and checking the information in the registry can access. Patients are identified by their physicians at each centre. The patient's information is recorded on paper, and then transcribed into the database by a research nurse working with the registry. Ten physicians are responsible for collecting, recording and checking the patient's information, 6 persons for transcribing the information into the registry,1 person for coordination, and 1 person for the web service.Until now, more than 1000 patients, classified as 4 kinds of hereditary kidney diseases, were registered.
Special issues
Inequalities in health care of children with ESRD -the case of Brazil P.C. Koch-Nogueira, M.F. Camargo, L. Feltran, T. Konstantyner, R.C. Sesso Hospital Samaritano, Sao Paulo and UNIFESP, Brazil Objectives: Regional discrepancies in health care are frequent among countries and even among regions of the same country. We aimed to determine the incidence and prevalence of ESRD in children (aged<18 years) in Brazil in 2012 and also to quantify regional inequalities. Methods: Data collection from both: a) a sample of 239 (out of 708 total) dialysis units randomly selected to represent geographic regions and b) the national transplant waiting list coordinated by the Ministry of Health from Brazil during the period 2010-2013. Results: We collected data from 643-paediatric and 36401-adult dialysis patients, yielding the estimation of a total of 1283 (95% CI 948 to 1618) pediatric and 104577 (95% CI 94673 to 114482) adult ESRD cases on dialysis throughout the country in 2012. This indicates pediatric prevalence of 20.0 (95%CI=14.8 to 25.3) cases per million (pm) and an adult prevalence of 539 (95%CI=488 to 590) cases pm in 2012. Prevalence in children contrasted among regions, being 13.8 pm in the North/Midwest, 16.4 pm in the Northeast, 23.3 pm in Southeast and 27.7 pm in the South. The main aetiologies of ESRD were indeterminate (38%), CAKUT (28%), glomerulonephritis (16%), systemic diseases (6%), FSGS (5%), congenital / hereditary diseases (5%) and other causes (2%). In addition, 1211 children were enrolled for renal transplantation in the study period. From these, 769 were transplanted, being 657 (85%) performed with deceased donor. The incidence of deceased donor paediatric transplant in 2012 was 4.1 cases pm and the hazard ratio for achieving a transplant after 2 years in the waiting list was significantly different among regions: a) 1.0 in the North/Midwest (reference), 2.8 in the Northeast, 4.4 in Southeast and finally 4.5 pm in the South (P<0.001). Conclusions: Existence of regions in Brazil with lower prevalence of ESRD and inferior likelihood of transplantation suggests that patients do not receive equitable health care in different areas of the country. There are regions with good indicators alongside others with poor performance.
The implementation and evaluation of multicenter school urine screening in China Objective: Understand asymptomatic urine abnormalities among primary & middle school students and effectiveness of the screening method. Methods: During Jan 2013 to Dec 2013, urine screening of students of 6-7 and 12-13 years of age in 11 provinces, municipalities and autonomous regions were carried out. Urine samples were collected by unified method and tested by unified urine dipsticks artificially by eyes. The observation indices included urine occult blood and protein. Those who were positive should be tested again in 2 weeks by the same method. The screening method was assessed then. Results: 1) Screening results: A total of 40,774 primary school students and 43,394 middle school students completed the screening, the average positive rate of first test was 8.76 (3.18-16.58%) and 3.18 (3.00-27.16%). And isolated hematuria (IH) or occult blood, isolated proteinuria (IP), hematuria associated with proteinuria (IH+IP) accounted 7.62% and 6.78%, 0.87% and 1.67%, 0.27% and 0.53%, respectively. Then the average positive rate of secondary test was 2.92 (0.31-7.09%) and 0.31(0.34-14.79%). IH, IP and IH+IP accounted 2.56% and 2.56%, 0.26% and 0.80%, 0.11% and 0.38%, respectively. The proportion of IP and IH+IP was significantly higher in middle school students (P< 0.05). The positive rate in south cities was similar to foreign reports, while in north-west, it was high (7.09% and 14.79% in primary and middle school students), which was similar to the reported data of the large-scale urine screening among children in the late 1980s in China. 2) Evaluation of screening method: The school urine screening was conducted with physical examination of students. And two urine samples tested by dipstick, the direct cost was <1.8 RMB per person. What's more, it was easy to operate, not restricted by device and specific sites and the results were reliable. Meanwhile, false positives of double tests were significantly lower than one-time test. Conclusions: The prevalence of asymptomatic urine abnormalities among primary and middle school students in China was about 3%, implementation of school urine screening and follow-up of the positive detection should be paid attention to. Two urine samples tested by dipstick were cost-effective, suitable for different medical conditions. Standard training and quality control were essential as well. Objectives: The prevalence of proteinuria in children in Indonesia is not definitely known. The aim of the study is to determine the prevalence and related factors of proteinuria in primary school children in Bali. Methods: An analytic cross sectional study was conducted on elementary schools students in Bali from July 2013 to December 2013. Data were collected by examination & interviewed using questionnaire. Factors associated with proteinuria were analyzed using Chi-square test. Multivariate analysis was performed to the related factors with P <0.25 on the bivariate analysis. Results: One thousand and twenty students participated in this study. Prevalence of proteinuria was 2.6%. Male gender, 10-12 years age group, hypertension and renal diseases in parents were related factors for the occurrence of proteinuria with a significance value P<0.05. Multivariate analysis showed hypertension was associated with frequency of proteinuria [OR 4.5, 95% CI 1.2 to 16.9, P=0.02], and 10-12 years age group also associated with frequency of proteinuria [OR 7.13, 95% CI 1.59 to 32.02, P=0.01]. Conclusion: The prevalence of proteinuria in primary school children in Bali is 2.6%. Hypertension and 10-12 years age group are factors that related to frequency of proteinuria in primary school children in Bali. The prevalence of proteinuria depicts an increasing abnormalities and severity of renal kidney disease. An early detection of proteinuria by dipstick test is an important screening for an early marker for renal abnormalities.
Does malnutrition affect kidney size: Comparative study of size between malnourished and healthy children S. Gupta, P. Kumar, A. Mehta Division of Nephrology, Department of Pediatric Medicine, SMS Medical College, Jaipur, India Background: Kidney size is an important parameter in the evaluation of renal growth in children. Nutrition is one of the most important factors that determines the growth and size of the human body. Poor renal growth may have some long term consequences. This study planned to study effect of malnutrition on kidney size in the children under 5-yr of age and comparing them with healthy children. Methods Setting: Tertiary care, Department of Pediatrics and Radiodiagnosis, SMS Medical College, Jaipur Sample size: With 80% study power and α-error of 0.05 and assuming standard deviation of 10 mm 3 kidney volume and minimum difference to be detected of 5 mm body height 0.725 x 0.007184. Kidney volume/body height and kidney volume/BSA ratios were calculated. Results: There were 77 (56.2%) males and 60(43.8%) females in malnourished group while 68 (73.1%) males and 25(26.9%) females in control group. Malnourished children had smaller kidneys than their healthy controls, mainly affecting kidney length. However, relative renal volume and renal volume/BSA ratio of children with energy deficiency was higher than controls. These differences could be due to short stature and decreased body weight. The strongest correlation was found between height and kidney size in malnourished children. Conclusion: Kidney size differences of marasmic children should be kept in mind while assessing ultrasound imaging. Long-term consequences of poor renal growth, such as increased risk of hypertension or tendency to development of chronic renal insufficiency, need to be investigated.
Transplantation
Carotid intima-media thickness of pediatric kidney transplant recipients K. Sgambat, S. Clauss, M. Lasota, A. Moudgil Children's National, Washington DC Objectives: Increased carotid intima-media thickness (CIMT) is a known predictor of increased cardiovascular risk in adults, but there are limited data in pediatric transplant (TX) recipients. A prospective controlled study was conducted to investigate CIMT of lean and obese children in predominantly African American (AA) pediatric kidney TX cohort compared to healthy controls as well as change in CIMT over time. Methods: Pediatric TX recipients had the following parameters measured at baseline, 18 and 30 months post TX: CIMT, fasting glucose, HDL, triglycerides (TG), HbA1c, waist circumference percentile (WC), and blood pressure (BP). CIMT was measured using B-mode ultrasound imaging of right and left common carotid arteries and carotid bulbs. TX with metabolic syndrome (MS) were identified as those with ≥3 of the following criteria: HbA1c >5.6% or fasting glucose >100, BP >90 th percentile, central obesity (WC ≥95 th percentile), HDL <5 th percentile, TG > 95 th percentile. CIMT of Tx recipients were compared to 24 healthy pediatric controls. Results: Study group comprised of 28 pediatric kidney TX recipients (8 obese, 20 lean), age 13.1±0.75 yr, 59.2% AA. Controls were 24 healthy children of similar age and race. CIMT of TX was greater compared to healthy controls (0.47±0.002 vs. 0.46±0.001, P=0.05). CIMT of AA Tx was greater than AA controls (0.49±0.002 vs. 0.47±0.002, P=0.000). Mean CIMT of TX group improved over time from 0.47±0.002 mm at baseline to 0.46±0.002 mm at 18 months (P=0.01) and 0.44±0.003 mm (P=0.000) at 30 months post-tx. Obese TX had greater CIMT than lean TX (0.48±0.004 vs. 0.46±0.002, P=0.001). TX with MS had greater CIMT than those without MS (0.49±0.004 vs. 0.46±0.002 mm, P=0.000). AA TX had greater CIMT vs. non-AA TX (0.49±0.002 vs. 0.43±0.001, P=0.000). Conclusions: Pediatric kidney TX recipients carry increased CV risk, particularly those with MS, obesity and AA race. This is the first study to demonstrate that AA have higher CIMT compared with non-AA pediatric TX recipients. Further studies are needed to investigate strategies for decreasing CIMT after kidney TX, particularly in higher risk groups.
Prospective trial of attenuated live vaccines in children receiving immunosuppressants K. Kamei copies/mL (26464-275349 copies/mL) and 100 copies/mL (0-38082 copies/mL), respectively. In seven patients, EBV viral load was undetectable after RTX. After RTX therapy, five patients experienced neutropenia and 5 patients were admitted for viral or bacterial infection. During follow-up, rebound of EBV load along with recovery of B cells was observed in 4 patients. Conclusions: Preemptive RTX was effective for reducing EBV viral load in pediatric recipients of SOT. However, reduction of EBV viral load was not persistent and side effect of RTX, infection and neutropenia, was clinically significant. Department of Nephrology, Nanjing Children's Hospital, Nanjing; 2 Institute of Pediatrics, Nanjing Medical University, Nanjing, China Proteinuria serves as a direct causative factor of renal tubular cell injury and is highly associated with the progression of chronic kidney disease (CKD) via uncertain mechanisms. Recently, evidence demonstrated that both NLRP3 inflammasome and mitochondria are involved in the CKD progression. The present study was undertaken to examine the role of NLRP3 inflammasome/mitochondria axis in albumin-induced renal tubular injury. In patients with proteinuria, NLRP3 was significantly upregulated in tubular epithelial cells and was positively correlated with the severity of proteinuria. In agreement with these results, albumin remarkably activated NLRP3 inflammasome in both in vitro renal tubular cells and in vivo kidneys in parallel with significant epithelial cell phenotypic alteration and cell apoptosis. Genetic disruption of NLRP3 inflammasome remarkably attenuated albumin-induced cell apoptosis and phenotypic changes under both in vitro and in vivo conditions. In addition, albumin treatment resulted in a significant mitochondrial abnormality as evidenced by the impaired function and morphology, which was markedly reversed by invalidation of NLRP3/caspase-1 signaling pathway. Interestingly, protection of mitochondria function by MnTBAP or CsA robustly attenuated albumin-induced injury in mPTCs. Collectively, these findings demonstrated a pathogenic role of NLRP3 inflammasome/ caspase-1/mitochondria axis in mediating albumin-induced renal tubular injury. The discovery of this novel axis provides some potential targets for the treatment of proteinuria-associated renal injury. Objectives: Bartter syndrome (BS) and Gitelman syndrome (GS) are inherited autosomal recessive, salt-losing tubulopathies characterized by hypokalemic metabolic alkalosis. Phenotypic overlap occurs between type III BS and GS, which are difficult to distinguish based on clinical features. Furthermore, some acquired cases of pseudo-BS/GS (p-BS/GS) present clinical symptoms identical to BS/GS. Therefore, accurate diagnoses of these diseases are important, but differences among their clinical features have rarely been analyzed. Methods: We retrospectively studied 163 patients (type III BS: 30; GS: 90; p-BS/GS: 43) to establish distinctions between these conditions. Results: p-BS/GS patients were significantly older at diagnosis than type III BS and GS patients (P <0.05). Adult patients with p-BS/GS included a significantly higher percentage of women (P <0.05), and had a lower body mass index (BMI) (P <0.05) and estimated glomerular filtration rate (eGFR) (P <0.05) compared with adult GS patients. Furthermore, p-BS/ GS patients had significantly higher serum magnesium levels (P <0.05) and urinary calcium/ creatinine ratio (P <0.05) than GS patients. Although hypomagnesemia and hypocalciuria were leading biochemical findings in patients with GS, five patients with type III BS (16.7%) and 10 with p-BS/GS (23.3%) also showed hypomagnesemia and hypocalciuria and only 41 (45.6%) GS patients presented with both hypomagnesemia and hypocalciuria. Twelve patients with type III BS (40%) presented with chronic kidney disease (CKD), compared with 11 patients with GS (12%), and 27 with p-BS/GS (62.8%).
Conclusions:
The results of the present study also confirmed the significant phenotypic overlap in serum magnesium levels and urinary calcium/ creatinine ratios and incidence of CKD between these three diseases. Our results suggest that p-BS/GS usually occurs in adult women with lower BMI and eGFR. These findings clarify the clinical distinctions among type III BS, GS and p-BS/GS. Methods: We analyzed mutations in CLCN5 and OCRL genes and clinical phenotype of 9 unrelated Chinese patients with Dent disease. Results: Of 9 unrelated patients with Dent disease, 7 possessed mutations in CLCN5 (Dent-1), of which 6 were novel mutations; 2 patients showed mutations in OCRL (Dent-2), one of which were novel. Two patients had de novo mutations. Low-molecular-weight (LMW) proteinuria and hypercalciuria were found in all the 9 patients. Six patients showed nephrocalcinosis. In addition, three patients did renal biopsy and the pathological changes were mesangial proliferative glomerulonephritis, IgA nephropathy with thin basement membrane disease and minimal change glomerulopathy, respectively. Two patients with mutations in OCRL showed no mental retardation. Conclusions: These results suggest that various renal pathologic changes can be found in Dent disease. Gene analysis is critical for the diagnosis and differential diagnosis of Dent-1 and Dent-2.
Urolithiasis in Asian children: evaluation of metabolic factors

M. Naseri Dr Sheikh Children Hospital, Mashhad University of Medical Sciences, Iran
Objective: This study was conducted to review urolithiasis in Asian children with a focus on urinary metabolic factors. Materials: A literature search of Pub Med and Google identified pertinent articles from 20 different Asian countries which were subsequently reviewed. A totally of 12913 children (M/F ratio of 2.37:1) were enrolled in the studies. Results: Hypercalciuria, hyperuricosuria, hyperoxaluria, hypocitraturia and decreased urinary magnesium excretion were reported in 652 of 4509 (14.45%), 276 of 3137 (8.8%), 1053 of 3973 (26.5%), 1940 of 2846 (68.2%), 32 of 240(13.3%) of subjects, respectively. Cystinuria was noted in 112 of 4106 (2.7%) and mixed metabolic abnormalities were found in 175 of 724 (24.2%) patients. Association of urinary tract infection with stone disease was common (2454 of 6430; 38.16%). Urologic abnormalities were uncommon and recorded in only 447 of 9788 patients (4.5%).
ameliorate UUO-induced renal fibrosis. However, the protective effect of combination therapy with aliskiren and MZR against renal fibrosis is unknown. In this study, we investigated the synergistic effects of combination therapy with aliskiren and MZR on UUO-induced fibrosis in rats. Methods: Sprague-Dawley male rats underwent UUO, followed by treatment with either aliskiren, MZR, or both drugs. Kidney samples were fixed for histopathology and immunohistochemistry of myofibroblasts (α-smooth muscle actin; α-SMA) and macrophages (ED-1). Real-time quantitative reverse transcription polymerase chain reaction (RT-PCR) was performed to measure the expression of α-SMA, transforming growth factor-β1 (TGF-β1), osteopontin (OPN), monocyte chemotactic protein-1 (MCP-1) and renin.
Results: The scores for tubular dilatation, interstitial volume, and α-SMA expression following UUO were significantly reduced by combination therapy compared with monotherapy with either aliskiren or MZR. Combination therapy also caused a significant decrease in the number of ED-1 positive cells and expression of TGF-β1 gene compared with monotherapy with either drug (both P<0.05). Combination therapy also decreased the expression of OPN and MCP-1 gene (P<0.05). Conclusion: Combination therapy with aliskiren and MZR provides increased renal protection against renal fibrosis and UUO-induced inflammation. In view of this synergistic protective effect, we suggest that combination therapy with aliskiren and MZR can be a clinical choice of early intervention for progressive renal dysfunction.
